Dr.Guttler’s Patient Thyroid Blog Post: Radiofrequency Ablation for Thyroid Papillary Microcarcinoma
1. Dr Allen Ho came to my center to observe a patient of mine having thyroid RFA for a thyroid nodule. Now he is doing thyroid RFA.
2. A total of 1770 patients from 15 studies were included in the meta-analysis.
80% had complete ablation of the cancer. Twenty-two patients (1.2%) had FNA-confirmed residual mPTC or a new mPTC. Overall tumor progression was found in 26 patients (1.5%), local residual mPTC in the ablation area was found in 7 tumors (0.4%), new mPTC was found in 15 patients (0.9%), and 4 patients (0.2%) developed lymph node metastases on follow-up
3. This study supports that RFA is a potentially safe and efficient tool to treat low-risk mPTCs.
4. Complication rates were low and manageable, typically resolving within 3 months after RFA treatment.
5. Long-term follow-up is needed to determine its oncologic utility in comparison to surgery and active surveillance.
6. I am treating micropapillary cancers with RFA if they fit the criteria for safety.
Call for an evaluation .31039308860 or email to email@example.com
Ask for Alicia.
Add Your Comment